EA202192382A1 - COMPOUNDS TARGETING PRMT5 - Google Patents

COMPOUNDS TARGETING PRMT5

Info

Publication number
EA202192382A1
EA202192382A1 EA202192382A EA202192382A EA202192382A1 EA 202192382 A1 EA202192382 A1 EA 202192382A1 EA 202192382 A EA202192382 A EA 202192382A EA 202192382 A EA202192382 A EA 202192382A EA 202192382 A1 EA202192382 A1 EA 202192382A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds targeting
pharmaceutically acceptable
compound
prmt5
targeting prmt5
Prior art date
Application number
EA202192382A
Other languages
Russian (ru)
Inventor
Коэн Вандик
Пьерр Жан-Мари Бернар Рабоассан
Жером Деваль
Леонид Бейгельман
Дэвид Макгоуэн
Янник Дебинг
Original Assignee
Алигос Терапьютикс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Алигос Терапьютикс, Инк. filed Critical Алигос Терапьютикс, Инк.
Priority claimed from PCT/US2020/025966 external-priority patent/WO2020205867A1/en
Publication of EA202192382A1 publication Critical patent/EA202192382A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В изобретении предложены соединение формулы (I) или его фармацевтически приемлемые соли, фармацевтические композиции, которые включают в себя описанное в изобретении соединение (включая фармацевтически приемлемые соли соединения, описанного в изобретении), и способы их синтеза. В изобретении также предложены способы лечения заболеваний и/или состояний с помощью соединения формулы (I) или его фармацевтически приемлемой соли.The invention provides a compound of formula (I) or pharmaceutically acceptable salts thereof, pharmaceutical compositions that include the compound described in the invention (including pharmaceutically acceptable salts of the compound described in the invention), and methods for their synthesis. The invention also provides methods for treating diseases and/or conditions with a compound of formula (I) or a pharmaceutically acceptable salt thereof.

EA202192382A 2019-12-11 2020-03-31 COMPOUNDS TARGETING PRMT5 EA202192382A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962946649P 2019-12-11 2019-12-11
PCT/US2020/025966 WO2020205867A1 (en) 2019-04-02 2020-03-31 Compounds targeting prmt5

Publications (1)

Publication Number Publication Date
EA202192382A1 true EA202192382A1 (en) 2022-01-18

Family

ID=80631263

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202192382A EA202192382A1 (en) 2019-12-11 2020-03-31 COMPOUNDS TARGETING PRMT5

Country Status (1)

Country Link
EA (1) EA202192382A1 (en)

Similar Documents

Publication Publication Date Title
MX2021011606A (en) Compounds targeting prmt5.
EA201792214A1 (en) COMPOUNDS OF SUBSTITUTE QUINAZOLINE
EA201992126A1 (en) JAK INHIBITORS CONTAINING 4-MEMBER HETEROCYCLIC AMIDE
EA201891703A1 (en) COMPOUNDS OF BENZOPIRAZOL AND THEIR ANALOGUES
EA201992601A1 (en) CONDENSED IMIDAZOPYPERIDINE COMPOUND, JAK INHIBITOR
EA202190681A1 (en) DIMETHYLAMINOAZETIDINE AMIDES AS JAK INHIBITORS
EA201991884A3 (en) G12C KRAS INHIBITORS
EA201790078A1 (en) MNK INHIBITORS AND RELATED METHODS
EA201690752A1 (en) INHIBITORS G12C KRAS
EA202090688A1 (en) BIS-AMIDE CONNECTIONS ACTIVATING SARCOMER AND VARIANTS OF THEIR APPLICATION
EA200702339A1 (en) SUBSTITUTED AMIDA DERIVATIVES AS AN INHIBITOR PROTEINKINASE INHIBITORS
EA202090530A1 (en) 1-BENZYL-2-IMINO-4-PHENYL-5-OXOIMIDAZOLIDINE DERIVATIVES AS HIV PROTEASE INHIBITORS
EA201992299A1 (en) COMPOUNDS BASED ON ASK1 INHIBITORS AND THEIR APPLICATION
EA201991894A1 (en) PIPERIDINE-SUBSTITUTED Mnk INHIBITORS AND RELATED WAYS
EA202191991A1 (en) NEW DERIVATIVES OF A HETEROTRICYCLIC COMPOUND AND THEIR APPLICATIONS
PH12021550825A1 (en) Quinoline derivatives as alpha4beta7 integrin inhibitors
EA202190686A1 (en) 5-7-MEMBER HETEROCYCLIC AMIDES AS JAK INHIBITORS
EA202090052A1 (en) IMIDAZOLE-CONTAINING ALK2 KINASE INHIBITORS
EA202193015A1 (en) CDK INHIBITORS
CY1124251T1 (en) CARBOXAMIDE DERIVATIVES
EA202091604A1 (en) INHIBITION OF THE ION CHANNEL A1 WITH A TRANSITOR RECEPTOR POTENTIAL
MX2021012105A (en) Pyrrole compounds.
EA202090959A1 (en) AMINE-SUBSTITUTED HETEROCYCLIC COMPOUNDS AS EHMT2 INHIBITORS, THEIR SALTS AND METHODS OF THEIR SYNTHESIS
EA202092253A1 (en) SUBSTITUTED IMIDAZOLIDIN-2-ONE DERIVATIVES AS PRMT5 INHIBITORS
EA201692298A1 (en) DERIVATIVES OF CARBOXAMIDES